Svetlana Lucas
Chief Business Officer; Director · 2 filings · Latest: May 11, 2026
aTYR PHARMA INC
Scribe Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SCTX | Svetlana Lucas | Chief Business Officer | Jul 23, 2026 | Purchase | $15.00 | 3,000 | $45.0K | 3,000 |